206 related articles for article (PubMed ID: 16105557)
1. The incidence and clinical features of heparin-induced thrombocytopenia.
Bartholomew JR
Semin Hematol; 2005 Jul; 42(3 Suppl 3):S3-8. PubMed ID: 16105557
[TBL] [Abstract][Full Text] [Related]
2. Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin.
Pohl C; Kredteck A; Bastians B; Hanfland P; Klockgether T; Harbrecht U
Neurology; 2005 Apr; 64(7):1285-7. PubMed ID: 15824368
[TBL] [Abstract][Full Text] [Related]
3. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
[TBL] [Abstract][Full Text] [Related]
4. Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.
Baroletti S; Piovella C; Fanikos J; Labreche M; Lin J; Goldhaber SZ
Thromb Haemost; 2008 Dec; 100(6):1130-5. PubMed ID: 19132240
[TBL] [Abstract][Full Text] [Related]
5. Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery?
Lubenow N; Hinz P; Ekkernkamp A; Greinacher A
Eur J Haematol; 2007 Sep; 79(3):187-90. PubMed ID: 17655709
[TBL] [Abstract][Full Text] [Related]
6. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
[TBL] [Abstract][Full Text] [Related]
7. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs.
Walenga JM; Jeske WP; Prechel MM; Bacher P; Bakhos M
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():69-80. PubMed ID: 15085468
[TBL] [Abstract][Full Text] [Related]
8. Heparin-induced thrombocytopenia in surgical patients.
Battistelli S; Genovese A; Gori T
Am J Surg; 2010 Jan; 199(1):43-51. PubMed ID: 20103065
[TBL] [Abstract][Full Text] [Related]
9. Heparin, low molecular weight heparin, and heparin-induced thrombocytopenia in the ICU.
Warkentin TE; Cook DJ
Crit Care Clin; 2005 Jul; 21(3):513-29. PubMed ID: 15992671
[TBL] [Abstract][Full Text] [Related]
10. Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital.
Ban-Hoefen M; Francis C
Thromb Res; 2009 Jun; 124(2):189-92. PubMed ID: 19195684
[TBL] [Abstract][Full Text] [Related]
11. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism.
Stein PD; Hull RD; Matta F; Yaekoub AY; Liang J
Am J Med; 2009 Oct; 122(10):919-30. PubMed ID: 19682670
[TBL] [Abstract][Full Text] [Related]
12. Heparin-induced thrombocytopenia with acute aortic and renal thrombosis in a patient treated with low-molecular-weight heparin.
Chevalier J; Ducasse E; Dasnoy D; Puppinck P
Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):209-12. PubMed ID: 15649731
[TBL] [Abstract][Full Text] [Related]
13. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
ten Berg MJ; van den Bemt PM; Huisman A; Schobben AF; Egberts TC; van Solinge WW
Ann Pharmacother; 2009 Sep; 43(9):1405-12. PubMed ID: 19690229
[TBL] [Abstract][Full Text] [Related]
14. The safety of heparins in end-stage renal disease.
Sonawane S; Kasbekar N; Berns JS
Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia following cardiac surgery is associated with poor outcome.
Kuitunen A; Suojaranta-Ylinen R; Raivio P; Kukkonen S; Lassila R
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):18-22. PubMed ID: 17289474
[TBL] [Abstract][Full Text] [Related]
16. Heparin-induced thrombocytopenia after liver transplantation.
Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Makuuchi M
Transplant Proc; 2008 Jun; 40(5):1518-21. PubMed ID: 18589141
[TBL] [Abstract][Full Text] [Related]
17. [Heparin-induced thrombocytopenia: report of four cases in severely burned patients].
Bargues L; Foissaud V; Jault P; Samson T; Carsin H
Ann Fr Anesth Reanim; 2006; 25(11-12):1135-9. PubMed ID: 17034986
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolic complications of heparin-induced thrombocytopenia.
Giossi A; Del Zotto E; Volonghi I; Costa P; Bertuetti R; Remida P; Magoni M; Gasparotti R; Padovani A; Pezzini A
Blood Coagul Fibrinolysis; 2012 Sep; 23(6):559-62. PubMed ID: 22688553
[TBL] [Abstract][Full Text] [Related]
19. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
Rota E; Bazzan M; Fantino G
Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
[No Abstract] [Full Text] [Related]
20. Treatment of heparin-induced thrombocytopenia with fondaparinux.
Harenberg J; Jörg I; Fenyvesi T
Haematologica; 2004 Aug; 89(8):1017-8. PubMed ID: 15339691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
